IAG Holdings Ltd (8513) Fair Value & Analysis
Healthcare · HK · Market cap HK$34.8M
Fair value as of: Aug 13, 2026
From 11 valuation models · updated 3 days ago
Share price +1.6% over the past month.
Below-average quality, screening 57% undervalued on our models.
What matters now
- The large discount to fair value meets weak quality (42/100). That raises the risk this is a value trap rather than a bargain.
- The price is below even our cautious bear case (HK$0.3740). The market is more pessimistic than our downside scenario.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.
How to read this chart
60‑month range HK$0.3150 – HK$5.40 · fair‑value band HK$0.3740 – HK$0.6375 · the HK$0.3200 price screens below the HK$0.5015 fair value. Dashed = 300-day average. As of Aug 13, 2026.
Analysis
IAG Holdings Ltd (8513) currently trades at HK$0.3200, while our model-based Fair Value estimate is HK$0.5015, implying the stock looks roughly 56.7% undervalued today. The Quality Score stands at 42/100 (below-average quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium), always confirm before acting.
Over the trailing twelve months, IAG Holdings Ltd generated revenue of HK$18.6M at a net margin of -3.3%. Revenue grew 106.2% year over year. It earns a return on equity of -33.7%. Net debt stands at HK$1.5M. Fundamentals as of Aug 13, 2026
Our scenario range runs from HK$0.3740 (bear case) to HK$0.6375 (bull case); at HK$0.3200, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 80% below its 52-week high, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -46% fair-value upside, at 57%, 8513 screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 11 models by family
Widest divergence: Multiples (HK$0.0500) versus Asset-Based (HK$0.0100). Highest evidence: Growth DCF (80).
Notify me when 8513 reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 41 · Market factors (momentum, volatility) 18
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
MaxWin International Holdings Limited, an investment holding company, engages in the manufacture and sale of injection molded plastic parts for disposable medical devices in Asia. It operates through Component Parts, Sub-Assembly Parts, Data Solutions and Services, and Hospitality segments.
Full company description
MaxWin International Holdings Limited, an investment holding company, engages in the manufacture and sale of injection molded plastic parts for disposable medical devices in Asia. It operates through Component Parts, Sub-Assembly Parts, Data Solutions and Services, and Hospitality segments. It is also involved in manufacturing and trading of medical component parts and sub-assembly parts; sales of IT related products and rendering of maintenance services; provision of hotel accommodation hospitality services; and tooling services. In addition, the company manufactures plastics articles and products; provides technology and consulting services; trades in various goods; and offers big data solutions, and technical support and data services. MaxWin International Holdings Limited was formerly known as IAG Holdings Limited and changed its name to MaxWin International Holdings Limited in October 2023. The company was founded in 1981 and is headquartered in Singapore.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
IAG Holdings Ltd reported revenue of HK$18.6M in FY2025 versus HK$19.8M in FY2021, a compound −1.5%/yr. Reported net income was −HK$612K in FY2025.
Watch 8513: get an alert when its fair value changes →
Peer Group
Medical Instruments & Supplies · 202 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Medical Instruments & Supplies median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Medical Instruments & Supplies stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Intuitive Surgical, Inc ISRG | $401.27 | $150.04 | -63% |
| EssilorLuxottica Société anonyme 1EL | €164.40 | €68.55 | -58% |
| Medline Inc MDLN | $35.50 | $30.15 | -15% |
| Becton, Dickinson and Company BDX | $181.41 | $100.46 | -45% |
| Alcon Inc ALC | $73.58 | $39.78 | -46% |
| ResMed Inc RMD | $226.00 | $187.89 | -17% |
| West Pharmaceutical Services, Inc WST | $352.29 | $141.58 | -60% |
| Sartorius Stedim Biotech S.A DIM | €180.30 | €48.88 | -73% |
| Coloplast A/S COLOB | kr 429.70 | kr 382.22 | -11% |
| Gan & Lee Pharmaceuticals., a biopharmaceutical company, 603087 | ¥77.48 | ¥27.22 | -65% |
Compare IAG Holdings Ltd with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is IAG Holdings Ltd (8513) overvalued or undervalued?
What is the fair value of 8513?
What is the quality score of 8513?
What is the revenue of IAG Holdings Ltd (8513)?
What is the net profit margin of 8513?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track IAG Holdings Ltd and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.